Orbenin LA 200 mg intramammary suspension for lactating cattle and sheep
Orbenin LA 200 mg intramammary suspension for lactating cattle and sheep
Authorised
- Cloxacillin sodium monohydrate
Product identification
Medicine name:
Orbenin LA 200 mg intramammary suspension for lactating cattle and sheep
Orbenin LA 200 mg Suspension zur intramammären Anwendung für laktierende Kühe und Schafe
Active substance:
- Cloxacillin sodium monohydrate
Target species:
-
Cattle (dairy cow)
-
Sheep
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin sodium monohydrate210.08/milligram(s)1.00Applicator
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dairy cow)
-
Milk96hour
-
Meat and offal7day
-
-
Sheep
-
Meat and offal7day
-
Milkno withdrawal periodNot authorised for use in sheep producing milk for human consumption
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- (ID1) 36 gram(s): unspecified outer container with 12 Syringe (Low Density PolyEthylene) each with 3 gram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- HAUPT PHARMA LATINA
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402185.00.00
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0319/001
Concerned member states:
-
Italy
-
Netherlands
-
Poland
-
Portugal
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
